MT-2 (Melanotan 2) Complete Research Guide 2026 — Melanocortin Receptor Mechanism & Research Findings
MT-2 is a cyclic analog of alpha-melanocyte-stimulating hormone that activates multiple melanocortin receptor subtypes — producing research findings across pigmentation, sexual function, and appetite biology through a single compound's receptor promiscuity.
Melanotan 2 (MT-2) is a cyclic heptapeptide analog of alpha-melanocyte stimulating hormone (α-MSH), developed as a more stable and potent variant of the native melanocortin peptide. Its research profile spans several distinct biological domains because the melanocortin receptors it activates are distributed across multiple tissue types with different functional roles.
Melanocortin Receptor Subtypes and Selectivity
The melanocortin system comprises five receptor subtypes (MC1R through MC5R), each with distinct tissue distribution and function. MT-2 is a non-selective melanocortin receptor agonist — it activates multiple subtypes, which is the mechanistic source of its multi-domain research profile. MC1R activation in melanocytes drives pigmentation research; MC4R activation in the hypothalamus connects to sexual function and appetite research; MC3R activation contributes to energy homeostasis research.
Pigmentation Research
MC1R activation on melanocytes stimulates melanogenesis — the production and distribution of melanin — producing the pigmentation effects that define MT-2's most studied application. Research has documented increased melanin production in skin following MT-2 administration in animal and early human studies, with the UV-independent tanning effect that originally drove its development as a potential photoprotection research compound.
Comparison to PT-141
PT-141 (Bremelanotide) was developed from MT-2 as a more selective melanocortin research tool specifically for sexual function research, removing some of the non-selective receptor activity that causes MT-2's broader profile. Where MT-2 activates multiple melanocortin subtypes simultaneously, PT-141's development aimed to retain MC4R-mediated effects while reducing other receptor activity. The comparison is relevant for researchers studying the melanocortin system who want to isolate specific receptor-subtype effects.
Related Research Where to Buy MT-2 USA 2026 Where to Buy PT-141 USA 2026 Peptide Reconstitution Complete Guide
Research Use Only. DisclaimerFor laboratory and research use only. Not for human consumption. This content is educational and does not constitute medical advice.
Related Research Articles
PT-141 (Bremelanotide) Complete Research Guide 2026 — Melanocortin Mechanism & Findings
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist with a mechanism distinct from every other compound in its research area. Acting centrally through the nervous system rather than the vascular system, it represents a mechanistically unique research tool.
MT-2 (Melanotan 2) Complete Research Guide 2026
Complete Melanotan 2 research guide 2026. MC receptor pharmacology, MC1R pigmentation mechanism, MC4R central effects, pharmacokinetics and safety profile from published literature.
Melanotan 2 (MT-2) Benefits and Side Effects: A Research Guide
Published benefits, side effects, and PT-141/afamelanotide comparisons for Melanotan 2 — the parent compound of the melanocortin therapeutic category.
HCG Complete Research Guide 2026 — LH Receptor Mechanism & Testicular Function Research
Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone studied for its activity at the LH receptor, with research applications spanning testicular function, fertility-adjacent endocrine research, and HPG axis studies.
Neutral, moderated research discussion. Laboratory use only.
More compound guides, hubs, and educational research materials.